(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.98%.
Scholar Rock Holding's revenue in 2026 is $0.On average, 19 Wall Street analysts forecast SRRK's revenue for 2026 to be $692,836,469, with the lowest SRRK revenue forecast at $190,959,322, and the highest SRRK revenue forecast at $1,406,620,007. On average, 19 Wall Street analysts forecast SRRK's revenue for 2027 to be $18,186,196,161, with the lowest SRRK revenue forecast at $9,082,502,761, and the highest SRRK revenue forecast at $27,941,197,249.
In 2028, SRRK is forecast to generate $47,529,142,006 in revenue, with the lowest revenue forecast at $32,296,238,934 and the highest revenue forecast at $67,405,717,881.